Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000711537 | SCV000723141 | benign | not provided | 2020-03-13 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001082562 | SCV000771451 | benign | Charcot-Marie-Tooth disease axonal type 2O | 2025-01-28 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000711537 | SCV000841915 | benign | not provided | 2017-09-25 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002315921 | SCV000847518 | likely benign | Inborn genetic diseases | 2016-08-11 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
ARUP Laboratories, |
RCV000711537 | SCV001473139 | likely benign | not provided | 2019-07-25 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003980160 | SCV004789025 | likely benign | DYNC1H1-related disorder | 2024-01-05 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |